These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6172933)

  • 21. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies.
    Geier DA; Geier MR
    Neuro Endocrinol Lett; 2007 Oct; 28(5):565-73. PubMed ID: 17984958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated rates of testosterone-related disorders in women with autism spectrum conditions.
    Ingudomnukul E; Baron-Cohen S; Wheelwright S; Knickmeyer R
    Horm Behav; 2007 May; 51(5):597-604. PubMed ID: 17462645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen excess in women with acne alone compared with women with acne and/or hirsutism.
    Vexiau P; Husson C; Chivot M; Brerault JL; Fiet J; Julien R; Villette JM; Hardy N; Cathelineau G
    J Invest Dermatol; 1990 Mar; 94(3):279-83. PubMed ID: 2137846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum 3 alpha-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris.
    Joura EA; Geusau A; Schneider B; Söregi G; Huber JC
    Fertil Steril; 1996 Dec; 66(6):1033-5. PubMed ID: 8941077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
    Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
    Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma androgens in women with acne vulgaris.
    Lucky AW; McGuire J; Rosenfield RL; Lucky PA; Rich BH
    J Invest Dermatol; 1983 Jul; 81(1):70-4. PubMed ID: 6223099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher 17α-hydroxyprogesterone levels aggravated the severity of male adolescent acne in Northeast China.
    Wei B; Qu L; Zhu H; Xiao T; Wei HC; Chen HD; He C
    Dermatology; 2014; 229(4):359-62. PubMed ID: 25413081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen status in adolescent women with acne vulgaris.
    Aizawa H; Nakada Y; Niimura M
    J Dermatol; 1995 Jul; 22(7):530-2. PubMed ID: 7560449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prediction of increased levels of androgen in women with acne vulgaris using ultrasound and clinical parameters].
    Cibula D; Hill M; Fanta M; Skrenková J; Vohradníková O; Kudynová J; Zivný J
    Ceska Gynekol; 1999 Jul; 64(4):242-6. PubMed ID: 10568063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acne is not associated with abnormal plasma androgens.
    Levell MJ; Cawood ML; Burke B; Cunliffe WJ
    Br J Dermatol; 1989 May; 120(5):649-54. PubMed ID: 2527050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone and estradiol serum levels in acne.
    Yang XQ; Shen XL; Wu ER; Xia TA
    Chin Med J (Engl); 1989 Mar; 102(3):236-8. PubMed ID: 2527144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hirsutism and acne in women: coordinated radioimmunoassays for eight relevant plasma steroids.
    Fiet J; Gosling JP; Soliman H; Galons H; Boudou P; Aubin P; Belanger A; Villette JM; Julien R; Brérault JL
    Clin Chem; 1994 Dec; 40(12):2296-305. PubMed ID: 7988017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of hyperandrogenism: biochemical criteria.
    Stanczyk FZ
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):177-91. PubMed ID: 16772150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating hyperandrogenism: a challenge in acne management.
    Harper JC
    J Drugs Dermatol; 2008 Jun; 7(6):527-30. PubMed ID: 18561581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
    Vogt C; Dericks-Tan JS; Kuhl H; Taubert HD
    Gynecol Endocrinol; 1992 Jun; 6(2):85-90. PubMed ID: 1386956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea.
    Cupisti S; Dittrich R; Binder H; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):298-302. PubMed ID: 17516292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raised serum 11-deoxycortisol in men with persistent acne vulgaris.
    Ramsay B; Alaghband-Zadeh J; Carter G; Wheeler MJ; Cream JJ
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):305-10. PubMed ID: 7586599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.